Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients

The novel coronavirus infection has spread worldwide, causing a wide spectrum of clinical manifestations. Most patients develop moderate clinical illness, but a substantial number will experience severe pneumonia, which may rapidly progress to acute respiratory distress syndrome and multiple organ f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalkias, Athanasios, Mouzarou, Angeliki, Samara, Evangelia, Xanthos, Theodoros, Ischaki, Eleni, Pantazopoulos, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327460/
https://www.ncbi.nlm.nih.gov/pubmed/32613288
http://dx.doi.org/10.1007/s40291-020-00481-8
_version_ 1783552548194484224
author Chalkias, Athanasios
Mouzarou, Angeliki
Samara, Evangelia
Xanthos, Theodoros
Ischaki, Eleni
Pantazopoulos, Ioannis
author_facet Chalkias, Athanasios
Mouzarou, Angeliki
Samara, Evangelia
Xanthos, Theodoros
Ischaki, Eleni
Pantazopoulos, Ioannis
author_sort Chalkias, Athanasios
collection PubMed
description The novel coronavirus infection has spread worldwide, causing a wide spectrum of clinical manifestations. Most patients develop moderate clinical illness, but a substantial number will experience severe pneumonia, which may rapidly progress to acute respiratory distress syndrome and multiple organ failure. In this population, soluble urokinase plasminogen activator receptor (suPAR) could serve as a quick triage test and independent marker of clinical severity, hospital and intensive care unit admission, complications, and mortality.
format Online
Article
Text
id pubmed-7327460
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73274602020-07-01 Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients Chalkias, Athanasios Mouzarou, Angeliki Samara, Evangelia Xanthos, Theodoros Ischaki, Eleni Pantazopoulos, Ioannis Mol Diagn Ther Current Opinion The novel coronavirus infection has spread worldwide, causing a wide spectrum of clinical manifestations. Most patients develop moderate clinical illness, but a substantial number will experience severe pneumonia, which may rapidly progress to acute respiratory distress syndrome and multiple organ failure. In this population, soluble urokinase plasminogen activator receptor (suPAR) could serve as a quick triage test and independent marker of clinical severity, hospital and intensive care unit admission, complications, and mortality. Springer International Publishing 2020-07-01 2020 /pmc/articles/PMC7327460/ /pubmed/32613288 http://dx.doi.org/10.1007/s40291-020-00481-8 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Current Opinion
Chalkias, Athanasios
Mouzarou, Angeliki
Samara, Evangelia
Xanthos, Theodoros
Ischaki, Eleni
Pantazopoulos, Ioannis
Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
title Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
title_full Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
title_fullStr Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
title_full_unstemmed Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
title_short Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
title_sort soluble urokinase plasminogen activator receptor: a biomarker for predicting complications and critical care admission of covid-19 patients
topic Current Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327460/
https://www.ncbi.nlm.nih.gov/pubmed/32613288
http://dx.doi.org/10.1007/s40291-020-00481-8
work_keys_str_mv AT chalkiasathanasios solubleurokinaseplasminogenactivatorreceptorabiomarkerforpredictingcomplicationsandcriticalcareadmissionofcovid19patients
AT mouzarouangeliki solubleurokinaseplasminogenactivatorreceptorabiomarkerforpredictingcomplicationsandcriticalcareadmissionofcovid19patients
AT samaraevangelia solubleurokinaseplasminogenactivatorreceptorabiomarkerforpredictingcomplicationsandcriticalcareadmissionofcovid19patients
AT xanthostheodoros solubleurokinaseplasminogenactivatorreceptorabiomarkerforpredictingcomplicationsandcriticalcareadmissionofcovid19patients
AT ischakieleni solubleurokinaseplasminogenactivatorreceptorabiomarkerforpredictingcomplicationsandcriticalcareadmissionofcovid19patients
AT pantazopoulosioannis solubleurokinaseplasminogenactivatorreceptorabiomarkerforpredictingcomplicationsandcriticalcareadmissionofcovid19patients

Ejemplares similares